Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Core EBITDA Growth

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 18.691.19-0.11-4.0759.14

What is the latest Core EBITDA Growth ratio of VENUS REMEDIES ?

The latest Core EBITDA Growth ratio of VENUS REMEDIES is 18.69 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202518.69
Mar20241.19
Mar2023-0.11
Mar2022-4.07
Mar202159.14

How is Core EBITDA Growth of VENUS REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2025 18.69
1,470.59
Mar2024 1.19
Positive
Mar2023 -0.11
Negative
Mar2022 -4.07
Negative
Mar2021 59.14 -

Other Financial Ratios of VENUS REMEDIES


Compare Core EBITDA Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,451.2 Cr 13% 3% 205.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,725.0 Cr -3.2% 10.5% 9.3% Stock Analytics
DIVIS LABORATORIES ₹182,775.0 Cr 0.8% 9.5% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,764.0 Cr 2% 9.9% 35.4% Stock Analytics
CIPLA ₹113,007.0 Cr -1.9% 13.3% -6% Stock Analytics
DR REDDYS LABORATORIES ₹109,098.0 Cr -1.8% 7.4% 8.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

13%

3%

205.5%

SENSEX

0.2%

-4.9%

-8.4%


You may also like the below Video Courses